UPLC Separation Intergrates into Mass Spectrometers - - BioPharm International

ADVERTISEMENT

UPLC Separation Intergrates into Mass Spectrometers


BioPharm International
Volume 27, Issue 4, pp. 40-42

The new ionKey/MS System from Waters provides sensitivity, robustness, and ease-of-use out of mass spectrometry for applications ranging from bioanalyses to pharmacokinetic studies. Intended for use with Waters ACQUITY UPLC M-Class System and Xevo TQ-S Mass Spectrometer, the Waters ionKey/MS System integrates a UPLC separation into the mass spectrometer allowing scientists to achieve enhanced separation and detection of compounds, the company reports.

The ionKey/MS System’s iKey Microfluidic Separation Device contains fluidic connections, electronics, ESI interface, column heater, eCord Intelligent Chip Technology, and 1.7-micron UPLC grade particles inside a 150-micron I.D. channel to perform numerous UPLC separations without a degradation in performance. This plug-and-play design eliminates user-made connections, increasing data quality for scientists.

According to the company, ionKey/MS significantly reduces the amount of solvent consumed compared to 2.1-mm I.D. scale analyses, which results in lower solvent costs, reduced storage and disposal costs, and a more sustainable workflow for the environment.

Waters

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here